BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,029 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $222,229 | -3.0% | 4,360 | +2.3% | 0.09% | -8.4% |
Q3 2022 | $229,000 | -17.3% | 4,260 | -1.2% | 0.10% | -12.8% |
Q2 2022 | $277,000 | -21.8% | 4,310 | -5.5% | 0.11% | -0.9% |
Q1 2022 | $354,000 | -7.6% | 4,560 | +2.2% | 0.11% | -2.7% |
Q4 2021 | $383,000 | +6.7% | 4,460 | 0.0% | 0.11% | +2.7% |
Q3 2021 | $359,000 | +4.1% | 4,460 | 0.0% | 0.11% | +6.8% |
Q2 2021 | $345,000 | -5.0% | 4,460 | +3.7% | 0.10% | -10.4% |
Q1 2021 | $363,000 | +9.7% | 4,300 | +4.4% | 0.12% | -1.7% |
Q4 2020 | $331,000 | -6.5% | 4,120 | -6.4% | 0.12% | -18.8% |
Q3 2020 | $354,000 | -6.6% | 4,400 | 0.0% | 0.14% | -10.6% |
Q2 2020 | $379,000 | +6.2% | 4,400 | 0.0% | 0.16% | -11.0% |
Q1 2020 | $357,000 | -3.0% | 4,400 | 0.0% | 0.18% | +25.7% |
Q4 2019 | $368,000 | -10.5% | 4,400 | -6.4% | 0.14% | -6.5% |
Q3 2019 | $411,000 | +6.8% | 4,700 | 0.0% | 0.15% | +6.9% |
Q2 2019 | $385,000 | -9.0% | 4,700 | -9.6% | 0.14% | -7.7% |
Q1 2019 | $423,000 | +23.7% | 5,200 | 0.0% | 0.16% | +10.6% |
Q4 2018 | $342,000 | -14.7% | 5,200 | 0.0% | 0.14% | -0.7% |
Q3 2018 | $401,000 | +4.4% | 5,200 | 0.0% | 0.14% | +3.6% |
Q2 2018 | $384,000 | +13.6% | 5,200 | 0.0% | 0.14% | +10.5% |
Q1 2018 | $338,000 | +0.6% | 5,200 | 0.0% | 0.12% | +0.8% |
Q4 2017 | $336,000 | +0.9% | 5,200 | -1.9% | 0.12% | +12200.0% |
Q3 2017 | $333,000 | +1.8% | 5,300 | -1.9% | 0.00% | -99.2% |
Q2 2017 | $327,000 | +16.8% | 5,400 | 0.0% | 0.13% | +13.2% |
Q1 2017 | $280,000 | +1.1% | 5,400 | -13.6% | 0.11% | -2.6% |
Q4 2016 | $277,000 | -9.8% | 6,250 | -3.1% | 0.12% | -10.7% |
Q3 2016 | $307,000 | +5.1% | 6,450 | 0.0% | 0.13% | +6.5% |
Q2 2016 | $292,000 | +10.2% | 6,450 | 0.0% | 0.12% | +8.8% |
Q1 2016 | $265,000 | +7.7% | 6,450 | 0.0% | 0.11% | +3.7% |
Q4 2015 | $246,000 | +14.4% | 6,450 | -1.5% | 0.11% | +9.0% |
Q3 2015 | $215,000 | -53.1% | 6,550 | 0.0% | 0.10% | -49.0% |
Q2 2015 | $458,000 | +2.0% | 6,550 | 0.0% | 0.20% | +7.7% |
Q1 2015 | $449,000 | -6.5% | 6,550 | 0.0% | 0.18% | +12.3% |
Q4 2014 | $480,000 | -3.0% | 6,550 | -5.1% | 0.16% | -4.1% |
Q3 2014 | $495,000 | -51.8% | 6,900 | -51.3% | 0.17% | -9.6% |
Q2 2014 | $1,026,000 | -1.7% | 14,178 | 0.0% | 0.19% | -0.5% |
Q1 2014 | $1,044,000 | +5.9% | 14,178 | 0.0% | 0.19% | +3.3% |
Q4 2013 | $986,000 | +5.8% | 14,178 | 0.0% | 0.18% | +7.7% |
Q3 2013 | $932,000 | -36.3% | 14,178 | -33.0% | 0.17% | -6.1% |
Q2 2013 | $1,464,000 | – | 21,150 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |